Most recently, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in related places as classical opioid receptors, it binds to some wide array of endogenous opioids. In contrast to most opioid receptors, this receptor acts to be a scavenger and does not activate